sec filing
IN
NASDAQ · INM
InMed Pharmaceuticals Inc.
Healthcare · Biotechnology
$1.32
Down-$0.01 (-0.75%)
Updated Oct 18, 2026, 4:26 PM
SID Score
3.7/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 2.52M
- P/E ratio
- -0.17
- Dividend yield
- 0.00%
- 52-week range
- $0.58 – $2.33
- Volume
- 4.36K
- Avg. volume
- 346.51K
Price performance · INM
INM price history
1M range · 20 trading sessions · Daily adjusted prices
Prices through Oct 16, 2026
INM closed at $1.32 after 20 trading sessions, down 4.35% for the selected period.
- Last close
- $1.32
- Period change
- -4.35%
- Period low
- $1.31
- Period high
- $1.40
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | $1.32 | $1.34 | $1.32 | $1.32 | 4.36K |
| Oct 15, 2026 | $1.31 | $1.34 | $1.31 | $1.33 | 17.6K |
| Oct 14, 2026 | $1.35 | $1.36 | $1.31 | $1.31 | 31.33K |
| Oct 13, 2026 | $1.34 | $1.365 | $1.33 | $1.33 | 28.24K |
| Oct 12, 2026 | $1.39 | $1.40 | $1.36 | $1.36 | 28.78K |
| Oct 9, 2026 | $1.35 | $1.44 | $1.35 | $1.36 | 56.13K |
| Oct 8, 2026 | $1.32 | $1.355 | $1.32 | $1.33 | 28K |
| Oct 7, 2026 | $1.35 | $1.35 | $1.33 | $1.33 | 20K |
| Oct 6, 2026 | $1.38 | $1.38 | $1.32 | $1.33 | 18.3K |
| Oct 5, 2026 | $1.36 | $1.39 | $1.33 | $1.33 | 29.77K |
| Oct 2, 2026 | $1.3701 | $1.385 | $1.33 | $1.33 | 28.34K |
| Oct 1, 2026 | $1.34 | $1.3699 | $1.32 | $1.35 | 99.97K |
| Sep 30, 2026 | $1.35 | $1.4099 | $1.34 | $1.36 | 60.67K |
| Sep 29, 2026 | $1.35 | $1.42 | $1.34 | $1.375 | 60.53K |
| Sep 28, 2026 | $1.3639 | $1.37 | $1.36 | $1.36 | 17.4K |
| Sep 25, 2026 | $1.38 | $1.40 | $1.35 | $1.38 | 101.11K |
| Sep 24, 2026 | $1.39 | $1.42 | $1.37 | $1.40 | 38.96K |
| Sep 23, 2026 | $1.39 | $1.41 | $1.375 | $1.38 | 53.68K |
| Sep 22, 2026 | $1.39 | $1.4423 | $1.37 | $1.39 | 38.34K |
| Sep 21, 2026 | $1.375 | $1.46 | $1.37 | $1.38 | 120.1K |
Latest INM news
The latest Smart Investors Daily articles mentioning INM.
Stock researchCompany · Financials
Company
Market Activity
Research & News
Loading stock research…

